Some of the factors driving the market are increase in incidence and prevalence of osteoporosis, osteoarthritis, degenerative disc disease, herniated disc, scoliosis, kyphosis, lordosis, Ankylosing spondylitis, sacroiliac joint dysfunction, and, spor...
The rising incidence of infectious and non-infectious diseases and demand for early detection, diagnosis & treatment, increasing government and private funding, increasing advancements in cell imaging technologies to reduce the cost & time du...
The factors such as rising incidences of respiratory diseases, rapid growth in the geriatric population requiring long term ventilation, increase in the number of premature birth and the emergence of the COVID-19 pandemic are the factors driving the ...
The potential of AI to seamlessly assist and guide the healthcare personnel in arriving at the accurate, precise and rapid diagnostic or therapeutic conclusions, to improve patient care, to empower individuals in their self-care, to optimize the vari...
The factors driving the genomics market are demand for early disease detection, diagnosis, and treatment, rising government and private funding, increasing awareness and reduced cost of genomics test, favorable reimbursement, increasing demand for pe...
Some of the factors driving the market are increase in incidence and prevalence of neurovascular diseases like cerebral aneurysm, stroke, arteriovenous malformations, and increase in the aging population, technological advancement, acquisitions and f...
Technological advancements in cell line engineering (gene editing tools) & cell line development technologies, screening technologies and process development are giving immense growth opportunities for the market...
Factors like emergence of next generation biotherapeutics, development of personalized and orphan indication therapies and the persistently escalating prevalence of chronic, communicable and autoimmune diseases are expected to boost the market growth...
Increasing radioisotopes application, rise in public awareness, use of SPECT/CT and PET/CT imaging scans (hybrid imaging) and advancements in technology are driving nuclear medicine market growth...
The contract biomanufacturing global market is driven by the increasing trend of outsourcing among the biopharmaceutical companies, availability of advanced bioprocessing capabilities among the contract bioservice providers and the escalating approva...
An increasing number of patients suffering from obesity and the rise in the aging population who are vulnerable to develop hernia, rising adoption of tension-free repair procedures and increasing demand for minimally invasive procedures, are driving ...
Some of the factors such as the increasing prevalence of infectious diseases, the requirement of early detection for infectious disease, increasing point of care diagnostics and rapid diagnostics, favorable reimbursements, technological advancements ...